TY  - RPRT
TI  - Topical Formulation of Repurposed FDA-Approved Compounds Inhibits Pseudomonas aeruginosa ExoU and Improves Corneal Infection Outcomes
AU  - Foulkes, D. M.
AU  - Mclean, k.
AU  - Held, M.
AU  - Harris, J. A.
AU  - Sun, Y.
AU  - Fothergill, J.
AU  - Price, V.
AU  - Byrne, D. P.
AU  - Tam, C.
AU  - Fernig, D.
AU  - Kaye, S. B.
PY  - 2025
DO  - 10.1101/2025.10.26.684634
UR  - https://www.biorxiv.org/content/10.1101/2025.10.26.684634v1
ID  - 10.1101/2025.10.26.684634
ER  -